Emergent Biosolutions Inc (EBS) stock is lower by -49.29% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives EBS stock a score of 29 out of a possible 100.
That rank is influenced by a short-term technical score of 2. EBS's rank also includes a long-term technical score of 5. The fundamental score for EBS is 80. In addition to the average rating from Wall Street analysts, EBS stock has a mean target price of $91.17. This means analysts expect the stock to increase 69.77% over the next 12 months.
EBS has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on EBS!
Emergent Biosolutions Inc (EBS) stock is higher by 7.19% while the S&P 500 has risen 0.38% as of 11:32 AM on Friday, Oct 1. EBS has risen $3.58 from the previous closing price of $50.10 on volume of 238,452 shares. Over the past year the S&P 500 has risen 27.89% while EBS is lower by -49.29%. EBS earned $5.50 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 9.76.
Click Here to get the full Stock Report for Emergent Biosolutions Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
